Personal information

No personal information available

Activities

Collapse all

Works (3)

Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

Journal of Clinical Oncology
2023-02-01 | Journal article
DOI: 10.1200/JCO.22.01010
Contributors: Jacobus Pfisterer; Florence Joly; Gunnar Kristensen; Joern Rau; Sven Mahner; Patricia Pautier; Ahmed El-Balat; Jean-Emmanuel Kurtz; Ulrich Canzler; Jalid Sehouli et al.
Source: check_circle
Crossref

Histotype-specific analysis of acid ceramidase expression in ovarian cancer

Virchows Archiv
2020-06-02 | Journal article
DOI: 10.1007/s00428-019-02728-0
Contributors: Ahmed El-Balat; Thomas Karn; Uwe Holtrich; Sven Becker; Stefan Kommoss; Balázs Győrffy; Michael S. Anglesio; David G. Huntsman; Zacharias Drosos; Achim Rody et al.
Source: check_circle
Crossref

Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary

Journal of Clinical Pathology
2018-12 | Journal article
DOI: 10.1136/jclinpath-2018-205292
Contributors: Ahmed El-Balat; Iryna Schmeil; Khayal Gasimli; Nicole Sänger; Thomas Karn; Andre Ahr; Sven Becker; Ruza Arsenic; Uwe Holtrich; Knut Engels
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Archives of gynecology and obstetrics. (1)
How many people are using ORCID?